0001562230-25-000090.txt : 20250813 0001562230-25-000090.hdr.sgml : 20250813 20250813124942 ACCESSION NUMBER: 0001562230-25-000090 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250813 DATE AS OF CHANGE: 20250813 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ascendis Pharma A/S CENTRAL INDEX KEY: 0001612042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-88586 FILM NUMBER: 251210127 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP PROVINCE COUNTRY: G7 BUSINESS PHONE: 45 70 22 22 44 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP PROVINCE COUNTRY: G7 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Capital International Investors CENTRAL INDEX KEY: 0001562230 ORGANIZATION NAME: EIN: 951411037 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: 333 SOUTH HOPE STREET STREET 2: 55TH FL CITY: LOS ANGELES STATE: CA ZIP: 90071 BUSINESS PHONE: 213-486-9200 MAIL ADDRESS: STREET 1: 333 SOUTH HOPE STREET STREET 2: 55TH FL CITY: LOS ANGELES STATE: CA ZIP: 90071 FORMER COMPANY: FORMER CONFORMED NAME: Capital Research & Management Co - Division 3 DATE OF NAME CHANGE: 20121114 SCHEDULE 13G 1 primary_doc.xml SCHEDULE 13G 0001562230 XXXXXXXX LIVE Common Stock 06/30/2025 0001612042 Ascendis Pharma AS 04351P101 TUBORG BOULEVARD 12 HELLERUP G7 NA Rule 13d-1(b) Capital International Investors DE 3099512 0 3109225 0 3109225.00 5.6 IA Ascendis Pharma AS TUBORG BOULEVARD 12, HELLERUP, Denmark Capital International Investors 333 South Hope Street, 55th Fl, Los Angeles, CA 90071 N/A N IA 3,109,225 ** **Capital International Investors ("CII") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CII's divisions of each of the investment management entities collectively provide investment management services under the name "Capital International Investors." CII is deemed to be the beneficial owner of 3,109,225 shares or 5.6% of the 55,754,437 shares believed to be outstanding. Shares reported include 3,109,225 Depository Receipts, which represent 3,109,225 Common Stock. 5.6 3,099,512 0 3,109,225 0 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Capital International Investors Jae Won Chung 08/12/2025